(2023). Eligibility for Subcutaneous Implantable Defibrillator of Patients Undergoing Transvenous Implantable Defibrillator Extraction. test, 7(2), -. doi: 10.21608/cvrepj.2023.351303
. "Eligibility for Subcutaneous Implantable Defibrillator of Patients Undergoing Transvenous Implantable Defibrillator Extraction". test, 7, 2, 2023, -. doi: 10.21608/cvrepj.2023.351303
(2023). 'Eligibility for Subcutaneous Implantable Defibrillator of Patients Undergoing Transvenous Implantable Defibrillator Extraction', test, 7(2), pp. -. doi: 10.21608/cvrepj.2023.351303
Eligibility for Subcutaneous Implantable Defibrillator of Patients Undergoing Transvenous Implantable Defibrillator Extraction. test, 2023; 7(2): -. doi: 10.21608/cvrepj.2023.351303

Eligibility for Subcutaneous Implantable Defibrillator of Patients Undergoing Transvenous Implantable Defibrillator Extraction

Cardiovascular Research Prove Journal
Volume 7, Issue 2, December 2023    PDF (116.99 K)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2023.351303
Abstract
The subcutaneous implantable cardioverter
defibrillator (S-ICD) (Boston Scientific Inc.,
Natick, MA, USA) does not require the 
insertion of any elements into the
cardiovascular system and is an effective
alternative to the transvenous ICD for patients
not requiring pacing.
Statistics
Article View: 31
PDF Download: 36